Please login to the form below

Not currently logged in
Email:
Password:

Dr Ulf Jungnelius joins Oasmia Pharmaceuticals

He becomes senior medical advisor

Oasmia Pharmaceuticals Dr Ulf JungneliusOasmia Pharmaceuticals has appointed Dr Ulf Jungnelius as its new senior medical advisor.

He brings over 40 years of experience in oncology clinical research and development to the Uppsala, Sweden-based firm, having held leading positions in oncology at Eli Lilly, Pfizer and Takeda.

Most recently, Dr Jungnelius served as vice president, CR&D oncology at Celgene and continues serve as a partner for Healthcom, a healthcare technology company based in the US.

Julian Aleksov, executive chairman of Oasmia, said: “We are thrilled to add Dr Ulf Jungnelius, an individual with a very strong therapeutic area expertise and who has been a key driver in taking oncology blockbusters to regulatory approval and commercial success, to the Oasmia Pharmaceutical team.”

Meanwhile, Oasmia also announced Anders Lundin's resignation as chief financial officer.

Lundin joined the oncology drug developer in 2014, having previously served as head of finance at Galderma, a Swiss dermatology firm.

He will leave the company to pursue other business opportunities on 31 March.

5th February 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics